BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Norton SE, Ward-Hartstonge KA, Taylor ES, Kemp RA. Immune cell interplay in colorectal cancer prognosis. World J Gastrointest Oncol 2015; 7(10): 221-232 [PMID: 26483876 DOI: 10.4251/wjgo.v7.i10.221]
URL: https://www.wjgnet.com/1948-5204/full/v7/i10/221.htm
Number Citing Articles
1
Maya Vladova Gulubova, Dimitur Chavdarov Chonov, Koni Vancho Ivanova, Mariyna Kostova Hristova, Maria Magdalena Krasimirova-Ignatova, Tatyana Ivanova Vlaykova. Intratumoural expression of IL-6/STAT3, IL-17 and FOXP3 immune cells in the immunosuppressive tumour microenvironment of colorectal cancerImmune cells-positive for IL-6, STAT3, IL-17 and FOXP3 and colorectal cancer developmentBiotechnology & Biotechnological Equipment 2022; 36(1): 327 doi: 10.1080/13102818.2022.2072765
2
Marwan Fakih, Ching Ouyang, Chongkai Wang, Travis Yiwey Tu, Maricel C. Gozo, May Cho, Marvin Sy, Jeffrey A. Longmate, Peter P. Lee. Immune overdrive signature in colorectal tumor subset predicts poor clinical outcomeJournal of Clinical Investigation 2019; 129(10): 4464 doi: 10.1172/JCI127046
3
J. K. H. Leman, L. Munoz-Erazo, R. A. Kemp. Tumor Microenvironments in OrgansAdvances in Experimental Medicine and Biology 2020; 1226: 1 doi: 10.1007/978-3-030-36214-0_1
4
Roberta De Matteis, Magdalena B. Flak, Maria Gonzalez-Nunez, Shani Austin-Williams, Francesco Palmas, Romain A. Colas, Jesmond Dalli. Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancerScience Advances 2022; 8(5) doi: 10.1126/sciadv.abl5420
5
Atsushi Sugimoto, Tatsunari Fukuoka, Masatsune Shibutani, Hiroaki Kasashima, Kishu Kitayama, Masaichi Ohira, Kiyoshi Maeda. Prognostic significance of the Naples prognostic score in colorectal cancer patients undergoing curative resection: a propensity score matching analysisBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02722-6
6
Salman M. Toor, Rowaida Z. Taha, Varun Sasidharan Nair, Reem Saleh, Khaled Murshed, Mohamed Abu Nada, Eyad Elkord. Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancerCancer Immunology, Immunotherapy 2021; 70(3): 803 doi: 10.1007/s00262-020-02727-0
7
Theodoros Argyropoulos, Periklis G. Foukas, Effrosyni Karakitsou, Stefanos Konstantoudakis, Maria Kefala, Nektarios Koufopoulos, Nikolaos Machairas, Ioannis Panayiotides, Konstantinos Triantafyllou. Predictive Value of CD3, CD8, CD45RO Expression in Stage II/III Colorectal CancerInternational Journal of Reliable and Quality E-Healthcare 2018; 7(3): 18 doi: 10.4018/IJRQEH.2018070102
8
Pâmela Portela, Joice Merzoni, Juliana D. Lindenau, Daniel C. Damin, Timothy John Wilson, Rafael Roesler, Gilberto Schwartsmann, Luiz Fernando Jobim, Mariana Jobim. KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancerHuman Immunology 2017; 78(3): 263 doi: 10.1016/j.humimm.2017.01.003
9
Yidi Qu, Hongxin Yang, Siyu Li, Lanzhou Li, Yu Li, Di Wang. The involvement of Th1 cell differentiation in the anti-tumor effect of purified polysaccharide from Sanghuangporus vaninii in colorectal cancer via multi-omics analysisInternational Journal of Biological Macromolecules 2023; 237: 123927 doi: 10.1016/j.ijbiomac.2023.123927
10
Dwaipayan Chakraborty, Subhadip Pati, Sayantan Bose, Subhanki Dhar, Saikat Dutta, Gaurisankar Sa. Cancer immunotherapy: present scenarios and the future of immunotherapyThe Nucleus 2019; 62(2): 143 doi: 10.1007/s13237-019-00273-4
11
Srustidhar Das, Cristian Doñas, Paulina Akeus, Marianne Quiding-Järbrink, J. Rodrigo Mora, Eduardo J. Villablanca, Xiang Xue. β7 integrins contribute to intestinal tumor growth in micePLOS ONE 2018; 13(9): e0204181 doi: 10.1371/journal.pone.0204181
12
Chiara Porta, Alessandro Ippolito, Francesca Maria Consonni, Lorenzo Carraro, Giuseppe Celesti, Carmen Correale, Fabio Grizzi, Fabio Pasqualini, Silvia Tartari, Maurizio Rinaldi, Paolo Bianchi, Fiorella Balzac, Stefania Vetrano, Emilia Turco, Emilio Hirsch, Luigi Laghi, Antonio Sica. Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer ProgressionCancer Immunology Research 2018; 6(5): 578 doi: 10.1158/2326-6066.CIR-17-0036
13
Julia KH Leman, Sarah K Sandford, Janet L Rhodes, Roslyn A Kemp. Multiparametric analysis of colorectal cancer immune responsesWorld Journal of Gastroenterology 2018; 24(27): 2995-3005 doi: 10.3748/wjg.v24.i27.2995
14
Elizabeth A. Comen, Robert L. Bowman, Maria Kleppe. Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor MicroenvironmentFrontiers in Cell and Developmental Biology 2018; 6 doi: 10.3389/fcell.2018.00056
15
Bert H. O’Neil, John M. Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina A. Piha-Paul, Mark N. Stein, Albiruni R. Abdul Razak, Katia Dotti, Armando Santoro, Roger B. Cohen, Marlena Gould, Sanatan Saraf, Karen Stein, Sae-Won Han, Gregory Lesinski. Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinomaPLOS ONE 2017; 12(12): e0189848 doi: 10.1371/journal.pone.0189848
16
Maria E. Reyes, Marjorie de La Fuente, Marcela Hermoso, Carmen G. Ili, Priscilla Brebi. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in CancerFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00901
17
Jennifer K. Colby, Jonathan Jaoude, Fuyao Liu, Imad Shureiqi. Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancerCancer and Metastasis Reviews 2018; 37(2-3): 289 doi: 10.1007/s10555-018-9743-z
18
Virginia Niemi, Douglas Gaskarth, Roslyn A. Kemp. Extensive variability in the composition of immune infiltrate in different mouse models of cancerLaboratory Animal Research 2020; 36(1) doi: 10.1186/s42826-020-00075-9
19
Su-Man Kim, Eun-Mi Kim, Kon-Young Ji, Hwa-Youn Lee, Su-Min Yee, Su-Min Woo, Ja-Woon Yi, Chul-Ho Yun, Harim Choi, Hyung-Sik Kang. TREM2 Acts as a Tumor Suppressor in Colorectal Carcinoma through Wnt1/β-catenin and Erk SignalingCancers 2019; 11(9): 1315 doi: 10.3390/cancers11091315
20
Kirsten A Ward‐Hartstonge, Roslyn A Kemp. Regulatory T‐cell heterogeneity and the cancer immune responseClinical & Translational Immunology 2017; 6(9) doi: 10.1038/cti.2017.43
21
Tomohiro Kikuchi, Kosaku Mimura, Mai Ashizawa, Hirokazu Okayama, Eisei Endo, Katsuharu Saito, Wataru Sakamoto, Shotaro Fujita, Hisahito Endo, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze, Shinji Ohki, Kazunori Shimada, Kiyoshi Yoshimura, Takuya Tsunoda, Koji Kono. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancersCancer Immunology, Immunotherapy 2020; 69(1): 23 doi: 10.1007/s00262-019-02433-6
22
Wenhao Weng, Ajay Goel. Curcumin and colorectal cancer: An update and current perspective on this natural medicineSeminars in Cancer Biology 2022; 80: 73 doi: 10.1016/j.semcancer.2020.02.011
23
Dounia Chraa, Asmaa Naim, Daniel Olive, Abdallah Badou. T lymphocyte subsets in cancer immunity: Friends or foesJournal of Leukocyte Biology 2019; 105(2): 243 doi: 10.1002/JLB.MR0318-097R
24
Ming Cai, Ke Zhao, Lin Wu, Yanqi Huang, Minning Zhao, Qingru Hu, Qicong Chen, Su Yao, Zhenhui Li, Xinjuan Fan, Zaiyi Liu. Artificial intelligence-based analysis of tumor-infiltrating lymphocyte spatial distribution for colorectal cancer prognosisChinese Medical Journal 2024; 137(4): 421 doi: 10.1097/CM9.0000000000002964
25
Hui Wang, Tian Tian, Jinhua Zhang. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and PrognosisInternational Journal of Molecular Sciences 2021; 22(16): 8470 doi: 10.3390/ijms22168470